Biotronik Introduces Positive Data on Linox and Linoxsmart Leads

Biotronik has released positive data on the reliability and performance of its Linox and Linoxsmart cardioverter defibrillator leads.

In two registries evaluating 3,840 patients at 146 study centers in the U.S., the Linox leads demonstrated a 96.3 percent survival probability at five years, and 96.6 percent at four years for the Linoxsmart leads.

The long-term data from the GALAXY and CELESTIAL registries are available in the Journal of Cardiovascular Electrophysiology. — Anisa Jibrell